Recellularization of acellular human small intestine using bone marrow stem cells

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Gastroenterology

Background:

• The need for functional small intestine tissue for transplantation is critical.
• Current treatments for intestinal failure have limitations.
• Tissue engineering offers a promising alternative for creating functional intestinal grafts.

Purpose of the Study:

• To develop an acellular human small intestine scaffold.
• To investigate the recellularization potential of this scaffold with bone marrow stem cells.
• To create a functional tissue-engineered small intestine (TESI).

Main Methods:

• Human small bowel specimens were decellularized using a sequential treatment process.
• The decellularized scaffolds were recellularized with allogeneic bone marrow stem cells (EPCAM+ and CD133+).
• Histological, molecular, and immunofluorescence analyses were performed to assess scaffold integrity and recellularization.

Main Results:

• Decellularization effectively removed cellular and nuclear components while preserving the small intestine's histoarchitecture and extracellular matrix.
• Recellularization resulted in the repopulation of the scaffold with viable epithelial cells, smooth muscle cells, and endothelial cells.
• The engineered tissue exhibited key cellular markers and structural integrity, including goblet cells and blood vessels.

Conclusions:

• Decellularized human small intestine scaffolds can be successfully recellularized with bone marrow stem cells.
• The resulting tissue-engineered small intestine (TESI) demonstrates potential for clinical applications.
• Using the recipient's own immunocompatible bone marrow cells could eliminate the need for immunosuppression in future TESI therapies.